Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | GBA2 | Q9HCG7 | 1/20 | 0.44 |
| ▸ | GNAI3 | P08754 | 4/20 | 0.43 |
| ▸ | GNAO1 | P09471 | 4/20 | 0.43 |
| ▸ | GNAI1 | P63096 | 4/20 | 0.43 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | HRH2 | P25021 | 1/20 | 0.42 |
| ▸ | HRH1 | P35367 | 1/20 | 0.42 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | P2RY12 | Q9H244 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | ACHE | P22303 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9123475 | 0.98 | LMNA (0.55) | LMNAPOLBSMN1; SMN2GBA2GNAI3 | |
| SCHEMBL27694189 | 0.98 | LMNA (0.55) | LMNAPOLBSMN1; SMN2GBA2GNAI3 | |
| SCHEMBL17017 | 0.95 | POLB (0.63) | LMNAPOLBSMN1; SMN2GBA2GNAI3 | |
| SCHEMBL18760256 | 0.95 | POLB (0.63) | LMNAPOLBSMN1; SMN2GBA2GNAI3 | |
| SCHEMBL5820669 | 0.95 | POLB (0.63) | LMNAPOLBSMN1; SMN2GBA2GNAI3 | |
| Potassium SCHEMBL30906131 | 0.93 | POLB (0.61) | LMNAPOLBSMN1; SMN2GBA2GNAI3 | |
| SCHEMBL4082478 | 0.93 | POLB (0.61) | LMNAPOLBSMN1; SMN2GBA2GNAI3 | |
| Hydrochloric Acid SCHEMBL1111003 | 0.93 | POLB (0.61) | LMNAPOLBSMN1; SMN2GBA2GNAI3 | |
| SCHEMBL31093994 | 0.91 | LMNA (0.49) | LMNAPOLBSMN1; SMN2GBA2GNAI3 | |
| SCHEMBL112600 | 0.89 | SMN1; SMN2 (0.56) | LMNAPOLBSMN1; SMN2GBA2GNAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3409718-B1 | MODIFIER AND MODIFIED CONJUGATED DIENE-BASED POLYMER CONTAINING FUNCTIONAL GROUP DERIVED THEREFROM | LG CHEMICAL LTD (KR) | 2020-08-19 | — | — | EP | disclosed |
| US-10730984-B2 | Modifier and modified conjugated diene-based polymer including functional group derived therefrom | LG CHEM, LTD. (KR) | 2020-08-04 | — | — | US | disclosed |
| CN-108884271-B | Modifier and modified conjugated diene-based polymer containing functional group derived therefrom | 株式会社LG化学 | 2020-07-10 | — | — | CN | disclosed |
| EP-3409718-A1 | MODIFIER AND MODIFIED CONJUGATED DIENE-BASED POLYMER CONTAINING FUNCTIONAL GROUP DERIVED THEREFROM | LG Chem, Ltd. (KR) | 2018-12-05 | — | — | EP | disclosed |
| US-7279470-B2 | Compounds and uses thereof for decreasing activity of hormone-sensitive lipase | NOVO NORDISK A/S (DK) | 2007-10-09 | — | — | US | disclosed |
| US-7067517-B2 | Use of compounds for decreasing activity of hormone-sensitive lipase | NERO NORDISK A/S (DK) | 2006-06-27 | — | — | US | disclosed |
| EP-1458375-A2 | COMPOSITIONS FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE | NOVO NORDISK A/S (DK) | 2004-09-22 | — | — | EP | disclosed |
| EP-1458374-A2 | COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE | NOVO NORDISK A/S (DK) | 2004-09-22 | — | — | EP | disclosed |
| US-20030166644-A1 | Compounds and uses thereof for decreasing activity of hormone-sensitive lipase | NOVO NORDISK A/S (DK) | 2003-09-04 | — | — | US | disclosed |
| US-20030166690-A1 | Use of compounds for decreasing activity of hormone-sensitive | NOVO NORDISK A/S (DK) | 2003-09-04 | — | — | US | disclosed |
| WO-2003051841-A2 | COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE | NOVO NORDISK A/S (DK) | 2003-06-26 | — | — | WO | disclosed |
| WO-2003051842-A2 | COMPOSITIONS DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE | NOVO NORDISK A/S (DK) | 2003-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030166644-A1 | Compounds and uses thereof for decreasing activity of hormone-sensitive lipase | LIPE, PNLIP, LPL | LMNA 1410/4885POLB 3606/4885SMN1; SMN2 4233/4885 |
| US-10730984-B2 | Modifier and modified conjugated diene-based polymer including functional group derived therefrom | WASF2, ITGAM, ORMDL3 | LMNA 2448/4885POLB 4255/4885SMN1; SMN2 4376/4885 |
| US-20030166690-A1 | Use of compounds for decreasing activity of hormone-sensitive | LIPE, PNLIP, LPL | LMNA 2068/4885POLB 2734/4885SMN1; SMN2 4133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.